search
Back to results

Telemonitoring and Connected Care Applied to Multiple Sclerose (MonSter)

Primary Purpose

Multiple Sclerosis

Status
Active
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
MSmonitor, a self-management/education program with e-health interventions
Video calling program "Better-close"
Researchmanager program
Sponsored by
Isala
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Multiple Sclerosis

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

The participant is an MS patient who is being treated within the Isala. Is 18 years of age or older Has digital skills

The caregiver is the caregiver of an MS patient Is older than 18 years

Exclusion Criteria:

The patient does not master the Dutch language. The patient has insufficient computer skills. Disabled adults are excluded from the study.

Sites / Locations

  • University Medical Center Groningen
  • University of Maastricht
  • MS4research Institute
  • Isala

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Study group

Controlgroup

Arm Description

Studygroup: Working with MSmonitor and video calling. Complete research questionnaires every 3 months in the Case Report Form, Researchmanager.

Became care as usual (CAU), not working with MSmonitor or video calling. Complete research questionnaires every 3 months in the Case Report Form, researchmanager.

Outcomes

Primary Outcome Measures

The primary endpoint is Multiple Sclerose Quality of Life (MSQuol54)
The primary endpoint (MSQoL-54) at which the value of telemonitoring is determined is t=2 years.The 2 composite summary scores are the MSQOL-54 Physical Health Composite Score and the MSQOL-54 Mental Health Composite Score, The highest range is 100, de lowest 0. The lower the outcome (0) the better the quality of life. The higher the outcome (100), the worse the quality of life.

Secondary Outcome Measures

Impact on participation and autonomy (IPA)
An secondary outcome measure is the autonomy of the MS patient.
Work together on health (PIH)
Receiving care that suits the individual
Health questionnaire (Eq5D-5L)
The EQ-5D is a standardized instrument that scores on five health levels (mobility, self-care, daily activities, pain/discomfort, and anxiety/depression). From this, a weighted health index can be derived for an individual or population.
MS Self-Efficacy Scale (MSSES)
Confidence in being able to undertake daily activities and have control over activities related to MS.
Medical Consumption Questionnaire (iMCQ)
The iMCQ is a non-disease-specific questionnaire that aims to estimate the direct costs of medical care.
Productivity Costs Questionnaire (iPCQ)
The iPCQ aims to measure and subsequently value the indirect costs outside of healthcare: productivity costs
Patient satisfaction questionnaire (PTO)
Patient satisfaction questionnaire about care provided

Full Information

First Posted
January 23, 2022
Last Updated
October 6, 2023
Sponsor
Isala
search

1. Study Identification

Unique Protocol Identification Number
NCT05242731
Brief Title
Telemonitoring and Connected Care Applied to Multiple Sclerose
Acronym
MonSter
Official Title
MonSter Study, Telemonitoring and Connected Care Applied to Multiple Sclerose
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
April 29, 2021 (Actual)
Primary Completion Date
April 29, 2024 (Anticipated)
Study Completion Date
December 31, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Isala

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The investigators designed a new care concept based on a multi-modal version of the MSmonitor program, the 'MSmonitor-Plus and Video Calling Care' (MPVC). MPVC combines the self-management and education program MSmonitor with video consultations by using specific questionnaires designed for high-frequency/intensive self-assessments of MS patients. 'The overall objective of this study is to assess the feasibility and (cost)-effectiveness of MPVC compared to Care as Usual (CAU). An RCT with two parallel groups will be conducted to compare the MPVC with a CAU in MS patients and their caregivers. In this study, 208 MS patients will be included with follow-up measurements for two years (at baseline and every three months). After randomization, 104 patients will be assigned to MPVC and 104 patients to CAU. The study will consist of three parts: 1) a clinical effectiveness study, 2) a cost-effectiveness study, and 3) process evaluation.
Detailed Description
Multiple sclerosis (MS) is the most common neurological disorder (1:500-1000) in young adults. It has a profound impact on all aspects of human functioning. The clinical picture is comprehensive fatigue and often cognitive problems that negatively influenced the quality of life, but also the consultations in the hospital. MS is not curable. In recent years new treatments have become available. These are more effective (can slow down or even stop MS) but also have more side effects and are more expensive. Careful monitoring based on effectiveness and side effects is therefore important. The result is a high frequency of hospital visits and a great burden on the patient. This great burden is expressed in an increase in the fatigue and cognitive problems that are already present, so the consultation in the hospital provides less information and is less efficient than desired. Research has also shown, for example, that the complaints that MS patients discuss are mainly from the last 2 weeks. Previous complaints thus remain out of the picture The aim is to optimize care for MS patients and to improve their quality of life. The costs will also be considered. The telemonitoring will be done by MSmonitor-Plus program with video calling care (MPVC). The MS patients fill in specific questionnaires every 3 months in the MSmonitor Plus. The healthcare professionals (HCP) can view the answers remotely and coordinate the right care. If the telemonitoring shows that the patient is doing well, it can be decided that the patient does not have to come to the hospital for a check-up. By actively involving MS patients in the MSMonitor-Plus by filling in these questionnaires every 3 months, the HCP get a better picture of the complaints. All MS patients actively receiving treatment within Isala are eligible for this study. There is randomization in which telemonitoring is compared with standard treatment. One group, the control group (CG) (104) continues care as usual (CAU), the other group, the intervention group (IG) (104) receives MSMonitor Plus and video calling care (MPVC). During the research, both groups fill in research questionnaires every 3 to 6 months in an electronic case report form (Research Manager). These questionnaires are about general health, MS, health care consumption, autonomy, and quality of life are compared afterward. A cost-effectiveness analysis will be made of both groups. The study will last a total of 2 years for the participating patients. Previous studies have been done with MSM, but not for a long period.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Multiple Sclerosis

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Single center, randomized control, non inferiority trial
Masking
None (Open Label)
Allocation
Randomized
Enrollment
208 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Study group
Arm Type
Active Comparator
Arm Description
Studygroup: Working with MSmonitor and video calling. Complete research questionnaires every 3 months in the Case Report Form, Researchmanager.
Arm Title
Controlgroup
Arm Type
Active Comparator
Arm Description
Became care as usual (CAU), not working with MSmonitor or video calling. Complete research questionnaires every 3 months in the Case Report Form, researchmanager.
Intervention Type
Device
Intervention Name(s)
MSmonitor, a self-management/education program with e-health interventions
Intervention Description
A self-management/education program with e-health interventions
Intervention Type
Device
Intervention Name(s)
Video calling program "Better-close"
Intervention Description
Video calling program.
Intervention Type
Device
Intervention Name(s)
Researchmanager program
Intervention Description
Case Report Form, Datamanagement program
Primary Outcome Measure Information:
Title
The primary endpoint is Multiple Sclerose Quality of Life (MSQuol54)
Description
The primary endpoint (MSQoL-54) at which the value of telemonitoring is determined is t=2 years.The 2 composite summary scores are the MSQOL-54 Physical Health Composite Score and the MSQOL-54 Mental Health Composite Score, The highest range is 100, de lowest 0. The lower the outcome (0) the better the quality of life. The higher the outcome (100), the worse the quality of life.
Time Frame
2 years
Secondary Outcome Measure Information:
Title
Impact on participation and autonomy (IPA)
Description
An secondary outcome measure is the autonomy of the MS patient.
Time Frame
2 years
Title
Work together on health (PIH)
Description
Receiving care that suits the individual
Time Frame
2 years
Title
Health questionnaire (Eq5D-5L)
Description
The EQ-5D is a standardized instrument that scores on five health levels (mobility, self-care, daily activities, pain/discomfort, and anxiety/depression). From this, a weighted health index can be derived for an individual or population.
Time Frame
2 years
Title
MS Self-Efficacy Scale (MSSES)
Description
Confidence in being able to undertake daily activities and have control over activities related to MS.
Time Frame
2 years
Title
Medical Consumption Questionnaire (iMCQ)
Description
The iMCQ is a non-disease-specific questionnaire that aims to estimate the direct costs of medical care.
Time Frame
2 years
Title
Productivity Costs Questionnaire (iPCQ)
Description
The iPCQ aims to measure and subsequently value the indirect costs outside of healthcare: productivity costs
Time Frame
2 years
Title
Patient satisfaction questionnaire (PTO)
Description
Patient satisfaction questionnaire about care provided
Time Frame
2 years

10. Eligibility

Sex
All
Gender Based
Yes
Gender Eligibility Description
Because there are more women with MS than men (70% female - 30% male)
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: The participant is an MS patient who is being treated within the Isala. Is 18 years of age or older Has digital skills The caregiver is the caregiver of an MS patient Is older than 18 years Exclusion Criteria: The patient does not master the Dutch language. The patient has insufficient computer skills. Disabled adults are excluded from the study.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Dr E. (Esther) Zeinstra
Organizational Affiliation
Isala
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Prof. S (Silvia) Evers
Organizational Affiliation
Maastricht
Official's Role
Study Director
Facility Information:
Facility Name
University Medical Center Groningen
City
Groningen
State/Province
Nederland
ZIP/Postal Code
9713AV
Country
Netherlands
Facility Name
University of Maastricht
City
Maastricht
State/Province
Nederland
ZIP/Postal Code
6200MD
Country
Netherlands
Facility Name
MS4research Institute
City
Nijmegen
State/Province
Nederland
ZIP/Postal Code
6522KJ
Country
Netherlands
Facility Name
Isala
City
Zwolle
State/Province
Nederland
ZIP/Postal Code
7943KA
Country
Netherlands

12. IPD Sharing Statement

Citations:
PubMed Identifier
36371162
Citation
Hoving M, Jongen PJ, Evers SMAA, Edens MA, Zeinstra EMPE. MSmonitor-plus program and video calling care (MPVC) for multidisciplinary care and self-management in multiple sclerosis: study protocol of a single-center randomized, parallel-group, open label, non-inferiority trial. BMC Neurol. 2022 Nov 12;22(1):423. doi: 10.1186/s12883-022-02948-z.
Results Reference
derived

Learn more about this trial

Telemonitoring and Connected Care Applied to Multiple Sclerose

We'll reach out to this number within 24 hrs